Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit treatment naïve and therapy resistant forms ovarian cancer
2025 · npj Precision Oncology · 1 citations
https://doi.org/10.1038/s41698-025-00947-0
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
31
Citations
3
h-index
1
i10-index
Esther Rodman is an academic researcher from WinnMed. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Cytokine Signaling Pathways and Interactions & RNA modifications and cancer. The author has an h-index of 3, co-authored 16 publications.
ORCID: 0000-0003-0903-8251Click to start Chat